3.55
前日終値:
$3.63
開ける:
$3.57
24時間の取引高:
1.07M
Relative Volume:
0.46
時価総額:
$598.34M
収益:
$25.55M
当期純損益:
$-341.97M
株価収益率:
-1.2679
EPS:
-2.8
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
+2.60%
1か月 パフォーマンス:
+5.65%
6か月 パフォーマンス:
-23.16%
1年 パフォーマンス:
-44.18%
Relay Therapeutics Inc Stock (RLAY) Company Profile
RLAY を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RLAY
Relay Therapeutics Inc
|
3.55 | 598.34M | 25.55M | -341.97M | -304.44M | -2.80 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
459.41 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
538.11 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
324.13 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
546.04 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
240.99 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-17 | 開始されました | Wells Fargo | Equal Weight |
2024-09-10 | 再開されました | Goldman | Buy |
2024-09-10 | アップグレード | Jefferies | Hold → Buy |
2024-09-10 | ダウングレード | Oppenheimer | Outperform → Perform |
2024-05-10 | アップグレード | Barclays | Equal Weight → Overweight |
2023-04-20 | アップグレード | Jefferies | Underperform → Hold |
2023-04-19 | アップグレード | Raymond James | Outperform → Strong Buy |
2023-04-13 | 開始されました | Raymond James | Outperform |
2023-02-03 | 開始されました | Oppenheimer | Outperform |
2022-09-30 | 開始されました | Barclays | Equal Weight |
2022-09-02 | 開始されました | Stifel | Buy |
2022-06-06 | 開始されました | Jefferies | Underperform |
2022-02-01 | 開始されました | Berenberg | Buy |
2021-07-21 | 開始されました | BofA Securities | Buy |
2020-12-15 | 繰り返されました | H.C. Wainwright | Buy |
2020-12-08 | 開始されました | JMP Securities | Mkt Outperform |
2020-11-05 | 開始されました | H.C. Wainwright | Buy |
2020-08-10 | 開始されました | Cowen | Outperform |
2020-08-10 | 開始されました | Goldman | Buy |
2020-08-10 | 開始されました | Guggenheim | Buy |
2020-08-10 | 開始されました | JP Morgan | Neutral |
すべてを表示
Relay Therapeutics Inc (RLAY) 最新ニュース
In the Green: Relay Therapeutics Inc (RLAY) Closes at 3.06, Up/Down -6.42 from Previous Day - DWinneX
Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com India
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by California State Teachers Retirement System - Defense World
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors | RLAY Stock News - GuruFocus
Relay Therapeutics Appoints Claire Mazumdar to Board of Directors - citybiz
# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial - Investing.com India
# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial By Investing.com - Investing.com South Africa
Relay Therapeutics Appoints Claire Mazumdar To Board Of Directors - MarketScreener
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors - Bluefield Daily Telegraph
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 9,293 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - Insider Monkey
Relay Therapeutics Holds 2025 Annual Stockholder Meeting - TipRanks
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Relay Therapeutics (RLAY) Gets a Hold from Wells Fargo - The Globe and Mail
Relay Therapeutics Announces Lease Termination Agreement - TipRanks
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Bank of America Corp DE - Defense World
Citizens JMP maintains Relay Therapeutics stock rating after trial data By Investing.com - Investing.com Canada
Nuveen Asset Management LLC Increases Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Jane Street Group LLC Cuts Stock Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics reports promising breast cancer drug data By Investing.com - Investing.com South Africa
Relay Therapeutics’ RLY-2608 Shows Promising 11-Month PFS in Breast Cancer - Insider Monkey
Relay Therapeutics, Inc. Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival At Asco 2025 - MarketScreener
Relay Therapeutics (RLAY) Shares Positive Interim Results for RL - GuruFocus
Relay Therapeutics reports promising breast cancer drug data - Investing.com Australia
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 | RLAY Stock News - GuruFocus
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 - TradingView
Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Lifted by ProShare Advisors LLC - Defense World
Deutsche Bank AG Purchases 30,278 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Ameriprise Financial Inc. Purchases 28,989 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 17,009 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June - The Manila Times
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June | RLAY Stock News - GuruFocus
Relay Therapeutics Management to Share Latest Precision Medicine Strategy at Two Major Healthcare Conferences - Stock Titan
Relay Therapeutics’ SWOT analysis: ai-driven biotech stock faces pivotal year - Investing.com Nigeria
Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders - Quantisnow
Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders – Company Announcement - Financial Times
Man Group plc Buys Shares of 173,605 Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
What Makes Relay Therapeutics (RLAY) a New Buy Stock - MSN
Northern Trust Corp Buys 231,713 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
BNP Paribas Financial Markets Invests $987,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Stifel Financial Corp Makes New Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Transcript : Relay Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Relay Therapeutics, Inc. (RLAY): One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance
Relay Therapeutics Inc (RLAY) 財務データ
収益
当期純利益
現金流量
EPS
Relay Therapeutics Inc (RLAY) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
Catinazzo Thomas | Chief Financial Officer |
Apr 30 '25 |
Sale |
3.00 |
12,943 |
38,829 |
355,376 |
Catinazzo Thomas | Chief Financial Officer |
Apr 29 '25 |
Sale |
3.23 |
3,558 |
11,492 |
368,319 |
Catinazzo Thomas | Chief Financial Officer |
Apr 28 '25 |
Sale |
3.17 |
2,690 |
8,527 |
371,877 |
Bergstrom Donald A | President, R&D |
Apr 30 '25 |
Sale |
3.00 |
27,472 |
82,416 |
583,490 |
Bergstrom Donald A | President, R&D |
Apr 28 '25 |
Sale |
3.17 |
4,090 |
12,965 |
610,962 |
Adams Brian | Chief Legal Officer |
Apr 30 '25 |
Sale |
3.00 |
12,943 |
38,829 |
391,385 |
Adams Brian | Chief Legal Officer |
Apr 28 '25 |
Sale |
3.17 |
1,644 |
5,211 |
404,328 |
大文字化:
|
ボリューム (24 時間):